CAS: 1167985-17-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ozoralizumab REF: TM-T77126CAS: 1167985-17-2 | SDS-PAGE:> 95%;SEC-HPLC:95.6% | 311.00 €~2,422.00 € | Wed 30 Apr 25 |
 | Ozoralizumab REF: 3D-CLA1283CAS: 1167985-17-2 | - - - | To inquire | Mon 12 May 25 |
Ozoralizumab
CAS:1167985-17-2
Ozoralizumab (ATN-103) is a humanized anti-TNFα antibody and a novel TNFα inhibitor.
Purity:
SDS-PAGE:> 95%;SEC-HPLC:95.6%
Color and Shape:
Liquid
Molecular weight:
38.44 kDa
Ref: TM-T77126
| 1mg | 311.00 € | ||
| 5mg | 817.00 € | ||
| 10mg | 1,206.00 € | ||
| 25mg | 1,795.00 € | ||
| 50mg | 2,422.00 € |
Estimated delivery in United States, on Wednesday 30 Apr 2025
Ozoralizumab
CAS:1167985-17-2
Trivalent anti-tumour necrosis factor alpha (TNFα) antibody; inflammatory disease treatment
Ref: 3D-CLA1283
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 12 May 2025
